Coronavirus (COVID-19) Spike Receptor Binding Domain (300-600 a.a.)
Produktgrößen
50 µg
£547,00
32-6266-50UG
0.25mg
£1030,00
32-6266-0.25MG
Über dieses Produkt
- SKU:
- 32-6266
- Weitere Details:
- SOURCE : Escherichia Coli ; PHYSICAL APPEARANCE : Sterile Filtered clear solution ; The E.Coli derived recombinant protein contains the Coronavirus 2019 Spike Receptor Binding Domain (300-600 a.a.) immunodominant region; fused to His tag at C-terminal. A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus; 2019-nCoV was found in the fish market at the city of Wuhan; Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV; even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans. While bats are possibly the host of 2019-nCoV; researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
- Aufreinigung:
- CoV 2019 Spike Receptor Binding Domain Protein is >90% pure as determined SDS-PAGE.
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Store at -20[o]C.
- Hersteller:
- Abeomics
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules:Viral Particles
- Datenblatt des Herstellers:download_pdf.php